{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:19:20Z","timestamp":1793146760056,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04650-6","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:42:10Z","timestamp":1759520530000},"page":"3619-3630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world safety profile of bisoprolol: signal detection and demographic stratification using the FAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Kun","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"4","key":"4650_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ejhf.2830","volume":"25","author":"S Aktaa","year":"2023","unstructured":"Aktaa S, Gale CP, Brida M, Giannakoulas G, Kovacs G, Adir Y, Benza RL, B\u00f6hm M, Coats A, D\u2019Alto M, Escribano-Subias P, Ferrari P, Gali\u00e8 N, Gibbs JSR, Gin-Sing W, Hoeper MM, Humbert M, Lang IM, Maron BA, Meszaros G, Vonk Noordegraaf A, Price LC, Pepke\u2010Zaba J, R\u00e5degran G, Reis A, Sitbon O, Torbicki A, Ulrich S, Rosenkranz S, Delcroix M (2023) European society of cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 25(4):469\u2013477. https:\/\/doi.org\/10.1002\/ejhf.2830","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"4650_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8964","volume":"12","author":"VM Awad","year":"2020","unstructured":"Awad VM, Sakhamuru S, Kambampati S, Wasim S, Malik BH (2020) Mechanisms of beta-blocker induced psoriasis, and psoriasis de novo at the cellular level. Cureus 12(7):e8964. https:\/\/doi.org\/10.7759\/cureus.8964","journal-title":"Cureus"},{"issue":"7","key":"4650_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","volume":"30","author":"A Bate","year":"2007","unstructured":"Bate A (2007) Bayesian confidence propagation neural network. Drug Saf 30(7):623\u2013625. https:\/\/doi.org\/10.2165\/00002018-200730070-00011","journal-title":"Drug Saf"},{"issue":"6","key":"4650_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJ (2009) Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 18(6):427\u2013436. https:\/\/doi.org\/10.1002\/pds.1742","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"4650_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/ehf2.14255","volume":"10","author":"AH Behnoush","year":"2023","unstructured":"Behnoush AH, Khalaji A, Naderi N, Ashraf H, von Haehling S (2023) ACC\/AHA\/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Fail 10(3):1531\u20131544. https:\/\/doi.org\/10.1002\/ehf2.14255","journal-title":"ESC Heart Fail"},{"issue":"7","key":"4650_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/14740338.2020.1766022","volume":"19","author":"D Brasselet","year":"2020","unstructured":"Brasselet D, Chouchana L, Vial T, Damin-Pernik M, Lebrun-Vignes B (2020) Drug-induced retroperitoneal fibrosis: a case\/non-case study in the French PharmacoVigilance Database. Expert Opin Drug Saf 19(7):903\u2013914. https:\/\/doi.org\/10.1080\/14740338.2020.1766022","journal-title":"Expert Opin Drug Saf"},{"key":"4650_CR7","doi-asserted-by":"publisher","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M, Crisafulli S, Battini V, Carnovale C, Rafaniello C, Capuano A, Poluzzi E, Moretti U, Raschi E (2024) Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul 3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057","journal-title":"Front Drug Saf Regul"},{"issue":"9","key":"4650_CR8","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI107413","volume":"52","author":"AJ DiMarino","year":"1973","unstructured":"DiMarino AJ, Cohen S (1973) The adrenergic control of lower esophageal sphincter function. An experimental model of denervation supersensitivity. J Clin Invest 52(9):2264\u20132271. https:\/\/doi.org\/10.1172\/JCI107413","journal-title":"J Clin Invest"},{"key":"4650_CR9","doi-asserted-by":"publisher","unstructured":"D\u00fcngen, H. D., Apostolovic, S., Inkrot, S., Tahirovic, E., T\u00f6pper, A., Mehrhof, F., Prettin, C., Putnikovic, B., Neskovic, A. N., Krotin, M., Sakac, D., Lainscak, M., Edelmann, F., Wachter, R., Rau, T., Eschenhagen, T., Doehner, W., Anker, S. D., Waagstein, F., Herrmann-Lingen, C., \u2026 CIBIS-ELD investigators and project multicentre trials in the competence network heart failure (2011). Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.\u00a0European journal of heart failure,\u00a013(6), 670\u2013680. https:\/\/doi.org\/10.1093\/eurjhf\/hfr020","DOI":"10.1093\/eurjhf\/hfr020"},{"key":"4650_CR10","doi-asserted-by":"publisher","first-page":"1570868","DOI":"10.3389\/fcdhc.2025.1570868","volume":"6","author":"S Ertek","year":"2025","unstructured":"Ertek S, Caglar K (2025) Underestimated reason of hyperkalemia in diabetic patients: type IV renal tubular acidosis- mini review. Front Clin Diabetes Healthc 6:1570868. https:\/\/doi.org\/10.3389\/fcdhc.2025.1570868","journal-title":"Front Clin Diabetes Healthc"},{"issue":"6","key":"4650_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 10(6):483\u2013486. https:\/\/doi.org\/10.1002\/pds.677","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"4650_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10741-024-10461-3","volume":"30","author":"C Fonseca","year":"2025","unstructured":"Fonseca C, Garagarza C, Silva G, Caires G, Marques I, Lopes JA, Branco P, Alves R, Ferreira A (2025) Hyperkalemia management: a multidisciplinary expert panel\u2019s perspective on the role of new potassium binders. Heart Fail Rev 30(2):271\u2013286. https:\/\/doi.org\/10.1007\/s10741-024-10461-3","journal-title":"Heart Fail Rev"},{"key":"4650_CR13","unstructured":"Food and Drug Administration (FDA). (2023). FDA adverse event reporting system (FAERS) public dashboard. Retrieved from https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard"},{"issue":"30","key":"4650_CR14","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1002\/sim.8745","volume":"39","author":"SJ Heo","year":"2020","unstructured":"Heo SJ, Jung I (2020) Extended multi-item gamma Poisson shrinker methods based on the zero-inflated Poisson model for postmarket drug safety surveillance. Stat Med 39(30):4636\u20134650. https:\/\/doi.org\/10.1002\/sim.8745","journal-title":"Stat Med"},{"issue":"1","key":"4650_CR15","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim GK, Del Rosso JQ (2010) Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. The Journal of Clinical and Aesthetic Dermatology 3(1):32\u201338","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"issue":"1","key":"4650_CR16","doi-asserted-by":"publisher","DOI":"10.3892\/mi.2023.70","volume":"3","author":"Y Luo","year":"2023","unstructured":"Luo Y, Liu J, Feng W, Lin D, Song G, Chen M, Zheng H (2023) Use of \u03b2-blockers and risk of age-related macular degeneration among hypertensive patients: an insight from the National Health and Nutrition Examination Survey. Med Int 3(1):10. https:\/\/doi.org\/10.3892\/mi.2023.70","journal-title":"Med Int"},{"issue":"3","key":"4650_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/gut.27.3.260","volume":"27","author":"E Lyren\u00e4s","year":"1986","unstructured":"Lyren\u00e4s E, Abrahamsson H (1986) Beta adrenergic influence on oesophageal peristalsis in man. Gut 27(3):260\u2013266. https:\/\/doi.org\/10.1136\/gut.27.3.260","journal-title":"Gut"},{"issue":"1","key":"4650_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57(1):6\u201314. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02007.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"4650_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/12034754211004560","volume":"25","author":"S Mirali","year":"2021","unstructured":"Mirali S, Abduelmula A, Mufti A, Sachdeva M, Yeung J (2021) Drugs associated with the development of palmoplantar keratoderma: a systematic review. J Cutan Med Surg 25(5):553\u2013554. https:\/\/doi.org\/10.1177\/12034754211004560","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"4650_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.13225","volume":"38","author":"NM Muller","year":"2025","unstructured":"Muller NM, Tan SX, Vipulaguna N, Zhou C, Hughes MCB, Soyer HP, von Schuckmann L, Khosrotehrani K (2025) Beta-blockers and cutaneous melanoma outcomes: a systematic review and random-effects meta-analysis. Pigment Cell Melanoma Res 38(1):e13225. https:\/\/doi.org\/10.1111\/pcmr.13225","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"4650_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.nefroe.2023.12.002","volume":"43","author":"A Ortiz","year":"2023","unstructured":"Ortiz A, Gal\u00e1n CDA, Carlos Fern\u00e1ndez-Garc\u00eda J, Cerezo JG, Ochoa RI, N\u00fa\u00f1ez J, Guti\u00e9rrez FP, Navarro-Gonz\u00e1lez JF (2023) Consensus document on the management of hyperkalemia. Nefrologia 43(6):765\u2013782. https:\/\/doi.org\/10.1016\/j.nefroe.2023.12.002","journal-title":"Nefrologia"},{"issue":"3","key":"4650_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0735-6757(86)90072-0","volume":"4","author":"RJ Panos","year":"1986","unstructured":"Panos RJ, Tso E, Barish RA, Browne BJ (1986) Esophageal spasm following propranolol overdose relieved by glucagon. Am J Emerg Med 4(3):227\u2013228. https:\/\/doi.org\/10.1016\/0735-6757(86)90072-0","journal-title":"Am J Emerg Med"},{"issue":"6","key":"4650_CR23","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1053\/j.gastro.2021.12.289","volume":"162","author":"DA Patel","year":"2022","unstructured":"Patel DA, Yadlapati R, Vaezi MF (2022) Esophageal motility disorders: current approach to diagnostics and therapeutics. Gastroenterology 162(6):1617\u20131634. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.289","journal-title":"Gastroenterology"},{"issue":"27","key":"4650_CR24","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"4650_CR25","unstructured":"Razok, A., Romero Noboa, M. E., Sami, F., Patolia, K. N., & Tanveer, S. (2023). IgG4-related disease and isolated retroperitoneal fibrosis: a narrative review. IgG4-related disease and isolated retroperitoneal fibrosis: a narrative review.\u00a0ARP rheumatology,\u00a02(2), 155\u2013157."},{"issue":"8","key":"4650_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST (2004) The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 13(8):519\u2013523. https:\/\/doi.org\/10.1002\/pds.1001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl 1","key":"4650_CR27","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana J, Cutroneo P, Trifir\u00f2 G (2013) Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother 4(Suppl 1):S73\u2013S77. https:\/\/doi.org\/10.4103\/0976-500X.120957","journal-title":"J Pharmacol Pharmacother"},{"key":"4650_CR28","doi-asserted-by":"publisher","first-page":"1404904","DOI":"10.3389\/fneur.2024.1404904","volume":"15","author":"P Turcano","year":"2024","unstructured":"Turcano P, Jacobson J, Ghoniem K, Mullan A, Camerucci E, Stang C, Piat C, Bower JH, Savica R (2024) Impulse control disorders and use of dopamine agonists in early onset Parkinson\u2019s disease. Front Neurol 15:1404904. https:\/\/doi.org\/10.3389\/fneur.2024.1404904","journal-title":"Front Neurol"},{"issue":"10","key":"4650_CR29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29809","volume":"14","author":"D Voloshyna","year":"2022","unstructured":"Voloshyna D, Ehsan Ullah S, Jahan N, Yadlapalli SS, Zahoor MM, Shams Y, Sathish M, Sandhu QI, Saleem F (2022) Beta-blocker-induced erythrodermic psoriasis: a case report. Cureus 14(10):e29809. https:\/\/doi.org\/10.7759\/cureus.29809","journal-title":"Cureus"},{"issue":"2","key":"4650_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae020","volume":"8","author":"ZS Wallace","year":"2024","unstructured":"Wallace ZS, Katz G, Hernandez-Barco YG, Baker MC (2024) Current and future advances in practice: IgG4-related disease. Rheumatol Adv Pract 8(2):rkae020. https:\/\/doi.org\/10.1093\/rap\/rkae020","journal-title":"Rheumatol Adv Pract"},{"key":"4650_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.10.001","volume":"17","author":"S Watson","year":"2019","unstructured":"Watson S, Caster O, Rochon PA, den Ruijter H (2019) Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine 17:100188. https:\/\/doi.org\/10.1016\/j.eclinm.2019.10.001","journal-title":"EClinicalMedicine"},{"key":"4650_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.635494","volume":"12","author":"J-F Zhang","year":"2021","unstructured":"Zhang J-F, Wang X-X, Feng Y, Fekete R, Jankovic J, Wu Y-C (2021) Impulse control disorders in Parkinson\u2019s disease: epidemiology, pathogenesis and therapeutic strategies. Front Psychiatry 12:635494. https:\/\/doi.org\/10.3389\/fpsyt.2021.635494","journal-title":"Front Psychiatry"},{"key":"4650_CR33","doi-asserted-by":"publisher","first-page":"1635331","DOI":"10.3389\/fimmu.2025.1635331","volume":"16","author":"F Zhang","year":"2025","unstructured":"Zhang F, Wang Y, Liu F, Li Y, Liu X, Ren X, Yuan X (2025) Impact of beta blockers on cancer neuroimmunology: a systematic review and meta-analysis of survival outcomes and immune modulation. Front Immunol 16:1635331. https:\/\/doi.org\/10.3389\/fimmu.2025.1635331","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04650-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04650-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04650-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:06:56Z","timestamp":1772777216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04650-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4650"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04650-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since there are no individual human participants (as data are obtained from FAERS and EudraVigilance), \u201cConsent to Participate: not applicable.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}]}}